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ABSTRACT
We have previously shown that the Leishmania
genome possess two widespread families of
extinct retroposons termed Short Interspersed
DEgenerated Retroposons (SIDER1/2) that play a
role in post-transcriptional regulation. Moreover,
we have demonstrated that SIDER2 retroposons
promote mRNA degradation. Here we provide new
insights into the mechanism by which unstable
Leishmania mRNAs harboring a SIDER2 retroposon
in their 30-untranslated region are degraded. We
show that, unlike most eukaryotic transcripts,
SIDER2-bearing mRNAs do not undergo poly(A) tail
shortening prior to rapid turnover, but instead, they
are targeted for degradation by a site-specific
endonucleolytic cleavage. The main cleavage site
was mapped in two randomly selected SIDER2-
containing mRNAs in vivo between an AU dinucleo-
tide at the 50-end of the second 79-nt signature
(signature II), which represents the most conserved
sequence amongst SIDER2 retroposons. Deletion
of signature II abolished endonucleolytic cleav-
age and deadenylation-independent decay and
increased mRNA stability. Interestingly, we show
that overexpression of SIDER2 anti-sense RNA can
increase sense transcript abundance and stability,
and that complementarity to the cleavage region is
required for protecting SIDER2-containing tran-
scripts from degradation. These results establish a
new paradigm for how unstable mRNAs are
degraded in Leishmania and could serve as the
basis for a better understanding of mRNA decay
pathways in general.
INTRODUCTION
Leishmania are unicellular protozoan parasites that cause
a broad range of human diseases known as leishmaniases.
Apart from being an important human pathogen,
Leishmania is an evolutionary early branching unicellular
eukaryote that displays unique features regarding genome
organization and control of gene expression. In contrast
to other eukaryotes, its  8300 genes are organized as
large directional polycistronic clusters on the same DNA
strand, comprising up to 100 functionally unrelated genes
(1). Polycistronic transcription is initiated upstream of
each cluster at the strand-switch region by a RNA poly-
merase II (pol II) in the absence of typical pol II promoter
sequences and basal transcription factors (2). Individual
mRNAs are produced from polycistronic pre-mRNAs by
two co-transcriptional RNA-processing reactions, namely
trans-splicing, which adds the spliced leader RNA (SL
RNA) to the 50-terminus of protein-encoding RNAs and
30-cleavage/polyadenylation [reviewed in (3)]. Thus, regu-
lation of gene expression in Leishmania and related
kinetoplastid protozoa occurs almost exclusively at the
post-transcriptional level, and in most cases, sequences
within 30-untranslated regions (30-UTRs) have been
shown to play a key role in controlling either the stability
of mRNAs or the eﬃciency of their translation [reviewed
in (4,5)].
Regulated mRNA turnover is a highly important
process in the control of gene expression. For most eu-
karyotic mRNAs decay begins with a shortening of the
poly(A) tail by a variety of mRNA deadenylases.
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scripts by a protein complex composed of the decapping
enzymes DCP1/2 and the RNA helicase DHH1
facilitating a processive degradation of the mRNA body
by 50–30 exonucleases, including XRN1) (6). Alternatively,
deadenylated mRNAs can then be degraded from the 30-
end by a large protein complex containing mainly 30–50
exonuclease activities, known as the exosome (7). In
contrast to these exonuclease-based pathways, a small
number of mRNAs are targeted for decay via
endonucleolytic digestion or other specialized
quality-control pathways (8). Although most homologs
of eukaryotic mRNA decay enzymes have been identiﬁed
in Leishmania and the related Trypanosoma species
[reviewed in (4,5)], little is known however, about the
mechanisms controlling mRNA degradation in these
parasites. Decapping activity was detected in extracts of
the trypanosome L. seymouri (9), but no homologs of the
eukaryotic mRNA-decapping proteins DCP1 and DCP2
have been identiﬁed yet in any of the trypanosomatids
(4,10). In T. brucei, it was shown that knockdown of the
major mammalian deadenylase homolog CAF1 signiﬁ-
cantly delayed deadenylation and degradation of consti-
tutively expressed mRNAs, while the levels of unstable
transcripts remained unchanged (11). In contrast,
XRNA, a putative XRN1-related 50–30 exonuclease in
trypanosomes, was shown to play an important role in
the degradation of highly unstable, developmentally
regulated mRNAs (12). The exosome complex has been
characterized in T. brucei and L. tarentolae and it resem-
bles both the yeast and human exosomes in overall struc-
ture, although it appears to be of lesser complexity
(13–15). In T. brucei, the exosome seems to play a minor
role in mRNA degradation because RRP45 depletion,
which probably disrupts exosome integrity, did not
aﬀect degradation of many stable RNA species (14,16).
Destabilizing AU-rich (AREs) or U-rich (UREs)
elements have been associated with rapid turnover of
developmentally regulated transcripts in trypanosomes
(4) and Leishmania (17).
We have recently reported the presence of small
degenerated retroposons termed Short Interspersed
DEgenerated Retroposons (SIDERs) in the 30-UTRs of
a large number of Leishmania mRNAs (18). The  2000
SIDER elements identiﬁed in Leishmania are truncated
versions ( 0.55kb) of formerly active retroposons of the
ingi/L1Tc-related family that became extinct a long time
ago (19). SIDERs constitute the largest family of trans-
posable elements described so far in trypanosomatid
genomes, they are  70 times more abundant in
Leishmania compared to Trypanosoma species and can
be divided into two phylogenetically distinct subfamilies,
namely SIDER1 and SIDER2. The vast majority (95.4%)
of SIDER elements are located in intergenic regions (IRs)
between protein-coding genes and >75% are part of
in silico-predicted 30-UTRs (18,20,21). Given their
privileged location in 30-UTRs, SIDERs could act as cis-
acting regulatory elements. We hypothesize that the con-
siderable expansion of SIDERs within 30-UTRs and their
high-sequence diversity supply Leishmania with novel
genetic material that contributes to diversifying regulatory
functions and consequently help the parasite to gain an
evolutionary edge. Interestingly, members of the SIDER1
subfamily, previously referred to as the 450-nt conserved
element, were shown to play a role in translation regula-
tion (22,23). More recent studies demonstrated that
members of the SIDER2 subfamily promote mRNA de-
stabilization (18). Several SIDER2-bearing mRNAs in
L. major are expressed at lower levels compared to tran-
scripts lacking SIDER2 and are short lived due to a rapid
turnover conferred by sequences within SIDER2 (18).
This article provides a step forward towards our under-
standing of the mechanism underlying the rapid turnover
of unstable SIDER2-containing mRNAs in Leishmania.
We provide several lines of evidence that degradation of
SIDER2-containing mRNAs is initiated by site-speciﬁc
endonucleolytic cleavage within the second 79-nt signature
sequence of SIDER2 without prior shortening of the
poly(A) tail. Our data uncover a novel mechanism of
mRNA decay in parasitic protozoa that targets short-lived
mRNAs sharing a conserved retroposon signature
sequence in their 30-UTR.
MATERIALS AND METHODS
Leishmania culture. The L. major LV39 strain used in this
experiment was described previously (24). Promastigotes
were cultured at pH 7.0 and 25 C in SDM-79 medium
supplemented with 10% heat-inactivated FCS (Wisent)
and 5mg/ml hemin.
Plasmid constructions and transfections. The parent
plasmid pSPYNEOaLUC was described previously (22).
The plasmids LUC-30-UTR1270 and LUC-30-UTR3810
expressing the luciferase (LUC) reporter gene under the
control of the full-length 30-UTR of LmjF08.1270 and
LmjF36.3810, respectively, the plasmids LUC-
SIDER1270 and LUC-SIDER3810 lacking the whole
SIDER2 element, and the plasmids LUC-SIDER1270 and
LUC-SIDER3810 with the SIDER2 element alone cloned
downstream of the LUC gene were described elsewhere
(18). All chimeric LUC deletion constructs lacking either
the T-stretch, the ﬁrst (I) or the second (II) 79-nt signature
sequence or both signatures (I+II) from SIDER1270 and
SIDER3810 or an 80-nt region from the end of
SIDER3810 (Supplementary Table S1) were generated as
follows. The 30-UTR sequences were ampliﬁed by PCR as
two separate halves leaving out the sequences to be deleted
(size of the partial 30-UTR sequences is indicated in
Supplementary Table S1) using primers with inserted
BamHI and PstI restriction sites. All obtained PCR
products were ﬁrst cloned into the pCR2.1 vector
(Invitrogen) and then digested with BamHI and PstI
(New England Biolabs). The two corresponding
BamHI-PstI fragments were then subcloned into the
BamHI site downstream of the LUC gene in vector
pSPYNEOaLUC, thereby fusing the two partial se-
quences at the PstI site. The 435-nt-long IR of
LmjF36.3810 and the SIDER2 lacking the T-rich stretch
(SIDER-3810T) were ampliﬁed by PCR using Taq DNA
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striction sites (Supplementary Table S1). To engineer
plasmids expressing either the full-length sense
(SIDER1270s and SIDER3810s) or anti-sense SIDER2
elements [(SIDER1270as, SIDER3810as,
SIDER1270(HYG)as, SIDER3810(HYG)as or
SIDER3810(HYG)79IIas lacking the second signature
sequence (Supplementary Table S2)], SIDER2 sequences
from LmjF36.3810 and LmjF08.1270 were PCR-ampliﬁed
with primers containing BamHI restriction sites
(Supplementary Table S1) and cloned in either orientation
into the expression vector pSPaNEOa (25) or only in
the anti-sense orientation into vector pSPYHYGa
(C. Dumas unpublished data). The ORFmyc-30-UTR3810
and ORFmyc-30-UTR1270 constructs are described else-
where (M. Mu ¨ ller et al., in revision). All constructs have
been veriﬁed by sequencing. Puriﬁed plasmid DNA (10–
20mg, Qiagen Plasmid Mini Prep Kit) was transfected
into Leishmania by electroporation as described previously
(25). Stable transfectants were selected and subsequently
cultivated with 0.04mg/ml G-418 (Sigma) or 0.32mg/ml
of hygromycin B (Sigma). Stable transfectants were plated
on SDM-79 (2X) medium with 1.5% agar and the appro-
priate drug selection and individual clones were obtained
after 2 weeks. The plasmid copy number in each transfect-
ant (Supplementary Table S2) was evaluated by Southern
blot hybridization using the single copy BT1 (biopterin
transporter 1) gene as a probe for normalization and quan-
tiﬁcation with the ImageQuant 5.2 software. The chimeric
LUC mRNAs and the anti-sense SIDER2 transcripts in all
theabovevectorsareprocessedatthe50-endbysequencesin
the Leishmania a-tubulin IR (aIR). Correct processing at
the 30-end of the chimeric LUC reporter transcripts used in
this study (Supplementary Table S2) was conﬁrmed by 30-
RACE (rapid ampliﬁcation of cDNA ends) using an
oligo(dT) primer and speciﬁc primers complementary to
the 30-UTR sequences of transcripts 1270 and 3810.
Ampliﬁed RT-PCR fragments were cloned into vector
pCR2.1 and sequenced to map the poly(A)-addition sites.
Luciferase assays. The LUC activity of the recombinant
parasites was determined as described previously (23).
Brieﬂy, 4 10
7- and 2 10
7-mid-log phase L. major
promastigotes were harvested by centrifugation and the
pellet was resuspended in 5  cell lysis buﬀer (Promega,
http://www.promega.com) and frozen at  80 Ct o
complete cell lysis. Twenty microlitres of each thawed
lysate were then mixed with 100ml luciferase assay buﬀer
(Promega) containing D-luciferin potassium salt,
and LUC activity was measured in 96-well plates using
a Dynex MLX luminometer (Dynex MLX, http://www
.dynextechnologies.com).
DNA, RNA and protein manipulations. Genomic DNA
and total RNA of L. major promastigotes were extracted
using the DNAzol and TRIzol reagents (Invitrogen), re-
spectively, following the manufacturer’s instructions.
Southern and northern blot hybridizations were per-
formed following standard procedures. Double-stranded
DNA probes were radioactively labeled with
[a-
32P]dCTP using random oligonucleotides and the
Klenow enzyme (New England Biolabs). Strand-speciﬁc
RNA probes (riboprobes) were prepared using the
MAXIscript Kit (Ambion) including T7 polymerase,
[a-
32P]UTP and template DNA cloned into
vector pCR2.1 (Invitrogen) downstream of a T7
promoter site. To prepare soluble protein lysates for
western blots, L. major promastigotes were harvested by
centrifugation, washed with ice-cold HEPES–NaCl buﬀer
and the pellet was re-suspended in 1X Laemmli buﬀer.
Proteins were quantiﬁed using Amido Black 10B
(Bio-Rad), and 40mg of total protein extracts were
loaded onto 10% SDS–PAGE gels. After electrophoresis,
gels were transferred onto a polyvinylidene diﬂuoride
membrane (Immobilon-P; Millipore), and membranes
were reacted with a goat-anti-LUC primary antibody
(Promega) followed by a donkey-anti-goat secondary
antibody (Santa Cruz Biotechnology). Protein loading
was monitored by reincubating the membranes with a
mouse anti-a-tubulin antibody (Sigma). All incubations
were performed with a 1:10000 dilution of the antibody
in 5% milk. The immunoblot was visualized by chemilu-
minescence with an ECL+Detection Kit (GE Healthcare).
RNA and protein levels were estimated by densitometric
analyses using the ImageQuant 5.2 software.
RNA stability assays. To determine the half-lives of
SIDER2-containing transcripts, mid-log phase L. major
promastigotes were incubated with 10mg/ml of
actinomycin D (ActD; Sigma) at diﬀerent time points
toarrestdenovotranscription.Alltimepointsinclude5min
of centrifugation times. Total RNA was extracted from
each sample using Trizol reagent (Invitrogen) and sub-
jected to northern blot hybridization. Quantitation of the
diﬀerent transcript intensities was done by densitometric
analysis using the ImageQuant 5.2 software.
Deadenylation assay. For visualizing changes in the length
of the poly(A) tail, 40mg of total RNA from ActD-treated
parasites were subjected to digestion with RNase H
(Invitrogen), as described previously (17). Brieﬂy,
RNase H digestions were carried out in the presence of
a speciﬁc DNA oligonucleotide complementary to a
sequence within the 30-UTR (for 3810, 50-TGCAAAAC
ACAGAGAGTTCCCAAAG-30 and for 1270, 50-GTGC
GCCGTGTGAGGGCCCGGTCGG) located exactly at
300nt from the 30-end of the transcript with or
without oligo(dT) (Invitrogen) and in the presence of
an RNase inhibitor (RNaseOUT, Invitrogen). RNA
products were then separated on 5% denaturing poly-
acrylamide gels (Sequagel, National Diagnostics) and
transferred onto nylon membranes (Hybond XL,
Amersham). Blots were probed with puriﬁed PCR frag-
ments corresponding to the last 300nt of transcripts 3810
and 1270.
RNase protection assay. Speciﬁc in vivo endonucleolytic
cleavage products derived from the chimeric LUC
reporter mRNAs in selected LUC transfectants were
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RNA was isolated from L. major transfectants using
Trizol reagent and was subsequently treated with
RNase-free Turbo DNase (1U/mg RNA; Ambion) for
1h at 37 C to remove DNA contaminations. To
generate riboprobes for detection of in vivo cleavage
products, DNA fragments corresponding to the entire or
partial sense SIDER1270 from gene LmjF08.1270 or
SIDER3810 from gene LmjF36.3810 were either cloned
into the pCR2.1 vector (Invitrogen) in reverse orientation
upstream of a T7 promoter or ampliﬁed by PCR with
primers containing a T7 promoter sequence. Anti-sense
riboprobes were in vitro-transcribed and radiolabeled
using the MAXIscript Kit (Ambion) with [a-
32P]UTP
and 500ng puriﬁed DNA. The 480-nt SIDER1270
riboprobe contains the ﬁrst 460nt of SIDER1270 plus
another 20nt upstream of SIDER1270. The 600-nt
SIDER1270 riboprobe contains the ﬁrst 480nt of
SIDER1270 including the 20-nt upstream and an add-
itional 127nt of non-complementary sequence originating
from the pCR2.1 vector (68nt at the 50-end and 59nt at
the 30-end of the probe). The 400-nt SIDER3810
riboprobe contains the ﬁrst 400nt of SIDER3810. All
these riboprobes were generated by PCR. Plasmids were
linearized by digestion with HindIII and puriﬁed by gel
extraction (Qiagen). Radiolabeled RNAs were gel-puriﬁed
and then examined for RNase protection using the
RPAIII kit (Ambion) following the manufacturer’s in-
structions. Brieﬂy, radioactive riboprobes were mixed
with total Leishmania RNA and incubated overnight at
45 C to allow annealing. Samples were subsequently
digested with a mix of the RNases A/T1 to remove all
single-stranded (ss) RNA sequences. Protected
double-stranded RNA products were resolved on an 8%
polyacrylamide urea gel and visualized by autoradiog-
raphy. The RPA assays have been optimized according
the manufacturer’s instructions to minimize the possibility
of RNase A/T1 overdigestion. For the detection of
anti-sense SIDER2 expression, the corresponding sense
sequences were subjected to in vitro transcription,
labeling and RNase protection. A radiolabeled control
reaction was performed in parallel to conﬁrm the size
and integrity of the RNA on a 6% acrylamide gel.
Primer extension. Primer extension was used to conﬁrm
endonucleolytic cleavage and to map more precisely the
putative cleavage sites within the SIDER2 signature II
sequence. The size of the generated cDNA fragments
reﬂects the number of nucleotides between the labeled
primer and the 50-end of the cleaved RNA, when the
reverse transcriptase enzyme falls of its template.
Diﬀerent reverse primers of 20–40-nt length were
designed complementary to a region 100–200-nt down-
stream of the predicted cleavage sites (Supplementary
Table S1). Primers were labeled with [g-
32P]ATP following
the polynucleotide kinase protocol (PNK; New England
Biolabs). Total RNA was isolated from L. major
LUC-transfectants and quantiﬁed with the bioanalyzer
chip (Agilent Technologies). The 10pmol of labeled
primer and 30–70mg of total RNA were used in all
experiments. Primer extension reactions were carried out
using the SuperScript
TM III RT kit (Invitrogen) following
the manufacturer’s recommendations. A X174 DNA/
HinfI dephosphorylated DNA marker (Promega) was
labeled with [g-
32P]ATP and PNK (New England
Biolabs) according to the manufacturer’s recommenda-
tions and was used as a size marker. In addition, we
used a dideoxy-sequencing to precisely estimate the
cleavage sites at the nucleotide level. The ladder was
generated using the sequenase 2.0 kit (USB) with 1pmol
of primer P1-3810 and 5mg of ss plasmid DNA containing
the SIDER3810 sequence. Primer extension fragments and
markers were separated on 8% denaturating acrylamide
gels (Sequagel, National Diagnostics) and visualized by
autoradiography.
Reverse ligation-mediated PCR. Sixty micrograms of total
RNA, isolated with the Trizol reagent and puriﬁed using
the RNeasy clean-up kit (Qiagen) were subjected to
DNase treatment with 40U Turbo DNase I (Ambion)
and 240U of RNaseOUT (Invitrogen) for 60min at
37 C. The reaction was terminated by phenol–chloroform
extraction followed by ethanol precipitation.
Circularization of  40 and  20mg DNA-free RNA was
performed overnight at 16 C in a reaction volume of
400ml with 40 units of T4 ssRNA ligase (New England
Biolabs) and 80 units of RNaseOUT as described (26).
The reactions were terminated by phenol–chloroform ex-
traction and ethanol precipitation. Reverse transcription
was carried out with 50pmol of primer P5-1270-RL and
 10mg RNA using the Superscript
TM III RT kit following
the manufacturer’s recommendations. PCR ampliﬁcations
were performed during 30 cycles with 3ml cDNA, 50pmol
of primers P5-1270-RL and P2-1270-RL using a Taq
Polymerase PCR kit (Qiagen) in a 50-ml reaction
volume. For nested PCRs, 2ml PCR products were
re-ampliﬁed in a 50-ml reaction during 30 cycles with
50pmol for each of primers P6-1270-RL and
P2-1270-RL. PCR products in the expected size range
were gel-excised, puriﬁed and cloned into the TOPO
TA-cloning vector (Invitrogen). Twenty clones were sub-
sequently chosen for sequencing (10 clones for each a and
b; Supplementary Figure S4).
RESULTS
The highly conserved 79-nt signature II sequence of
SIDER2 retroposons is essential for degradation
of SIDER2-bearing mRNAs
We have previously demonstrated that members of
SIDER2 retroposons in L. major promote mRNA degrad-
ation and that transcripts containing a SIDER2 element in
their 30-UTR are often low abundant and short-lived (18).
More than 1200 SIDER2 retroposons have been identiﬁed
in L. major (18), but similar numbers were also found in
L. infantum and L. braziliensis (21). Generally, SIDER2
retroposons share three conserved motifs. These include
an  18-nt thymidine-rich stretch at the 50-end correspond-
ing to the former recognition site for an endonuclease
5870 Nucleic Acids Research, 2010, Vol.38, No. 17encoded by the autonomous DIRE elements followed by
two tandemly arranged boxes of 79nt each (signatures I
and II) representing the hallmark of trypanosomatid
retroposons and by an adenosine-rich stretch at the
30-end (18,19). Sequence alignment of SIDER3810 and
SIDER1270 conﬁrmed the presence of a T-rich stretch
and the two 79-nt signatures (Figure 1A).
To assess whether any of these conserved motifs plays a
role in SIDER2-mediated mRNA decay, we generated a
series of individual deletions within two distinct SIDER2
elements that are located in the 30-UTR of the previously
studied genes LmjF36.3810 (3810) encoding an
aminomethyltransferase and LmjF08.1270 (1270)
encoding a hypothetical protein (18). The eﬀect of these
deletions for both SIDER3810 and SIDER1270 on
mRNA degradation was evaluated using a luciferase
(LUC) reporter gene system (Figure 1; Supplementary
Figures S1 and S2). The conserved stretch of uridines
located in a GC-rich environment shares features with
U-rich instability elements and might contribute to
SIDER2-mediated mRNA degradation. Deletion of
31nt corresponding to the T-stretch region either from
the full-length 30-UTR of transcript 3810 (LUC-30-
UTR3810T) or from the SIDER3810 alone
(LUC-SIDER3810T) had neither eﬀect on LUC
mRNA abundance and its half-life nor on the amount
and activity of LUC protein (Supplementary Figure
S1A–D). In contrast, deletion of the whole SIDER2
sequence with (LUCSIDER3810) or without
(LUCSIDER3810T) the T-stretch greatly increased
LUC mRNA accumulation and half-lives to a similar
extent (242±23min versus 225±7min)
(Supplementary Figure S1B and D).
We next assessed the contribution of the two 79-nt sig-
nature sequences to SIDER2-mediated mRNA degrad-
ation. Deletion of both signature sequences from either
SIDER3810 (LUC-30-UTR381079I+II) or SIDER1270
(LUC-30-UTR127079I+II) retroposons increased LUC
mRNA levels to those of stable transcripts lacking the
whole SIDER2 (Supplementry Figure S2A–C). Higher ac-
cumulation of LUC-30-UTR127079I+II and LUC-30-
UTR381079I+II transcripts was due to an increase
in their half-lives from 50–65min (full-length transcripts)
to 150±7min and 245±18min, respectively
(Supplementary Figure S2B and C). Deletion of signature
I from the full-length 3810 30-UTR (LUC-30-
UTR381079I) had no eﬀect on LUC mRNA degrad-
ation or LUC protein levels. In contrast, deletion of
signature II (LUC-30-UTR381079II) increased mRNA
and protein levels to a similar extent than deletion of the
whole SIDER2 (Supplementary Figure S2A) or of both
signatures (3.2- versus 3.3- and 3.4-fold, respectively)
(Figure 1B). Deletion of signature II (79nt) also increased
the half-life of LUC-30-UTR381079II mRNA by
3.7-fold (65 versus 242min; Figure 2B and E). As an add-
itional control, an independent deletion of the same length
(80nt) but from the 30-end of SIDER3810 was made
(LUC-30-UTR381080), however this neither aﬀected
LUC mRNA nor LUC protein levels (Figure 1B).
Altogether, these data indicate that signature II which is
highly conserved amongst SIDER2 retroposons (21) is es-
sential for mRNA degradation.
Rapid turnover of unstable SIDER2-containing mRNAs
is deadenylation independent
To investigate further the mechanism of mRNA degrad-
ation mediated by SIDER2 retroposons, we set out to
determine which step of mRNA decay was targeted by
these elements. There are two general pathways by
which most eukaryotic mRNAs can be degraded
[reviewed in (6)]. In both cases, mRNA degradation
begins with the shortening of the poly(A) tail at the
30-end of the mRNA. Deadenylation typically leads to a
removal of the 50-cap structure, which exposes the mRNA
to 50–30 exonucleolytic degradation. Alternatively, follow-
ing deadenylation, mRNAs can be degraded in a 30–50
direction by the exosome. To test whether turnover of
SIDER2-containing transcripts is preceded by a rapid
deadenylation, we monitored changes in the poly(A) tail
lengths of LUC reporter transcripts harboring SIDER2 as
part of the full-length 30-UTR of transcripts 3810 and
1270 (LUC-30-UTR3810, LUC-30-UTR1270) at diﬀerent
time points after transcription arrest using actinomycin
D (ActD). To do this, LUC transcripts were speciﬁcally
cleaved at 300-nt upstream of the poly(A) tail via
oligonucleotide-directed RNase H cleavage (Figure 2A).
The resulting 30-products containing the poly(A) tail
were visualized by northern blot analysis using a probe
complementary to the last 300nt of transcripts 3810 and
1270 (Figure 2B and C). In addition, one sample in each
experiment was treated with oligo(dT), which cleaves oﬀ
the poly(A) tail and serves as a control for fully
deadenylated mRNA species. Although the overall signal
intensity of both uncut LUC-30-UTR3810 and LUC-30-
UTR1270 transcripts decreased during the course of
ActD treatment, there was no change in the apparent
length of the poly(A) tails (Figure 2B and C). Similar
deadenylation patterns were also observed with the en-
dogenous L. major transcripts 3810 and 1270 (data not
shown). In contrast, the poly(A) tails of the stable LUC
transcripts lacking either the whole SIDER2
(LUC-SIDER3810) or signature II only (LUC-30-
UTR381079II) were signiﬁcantly shortened (from
 100 to  10 or less adenosines), long before reaching
their half-lives (Figure 2D and E). It is evident that in
the case of the unstable SIDER2-containing transcripts,
the cleaved 30-end disappears much later than the
full-length uncut LUC transcripts, conﬁrming that
mRNA decay does neither initiate nor proceed from this
end. In contrast, both stable LUC transcripts lacking a
functional SIDER2 showed a faster disappearance of
their 30-end compared to the full-length uncut LUC tran-
script, in line with our conclusion that these mRNAs are
degraded progressively from the 30-end after being
deadenylated. Altogether, these data demonstrate that
stable Leishmania transcripts (without a functional
SIDER2) are slowly degraded after a progressive shorten-
ing of their poly(A) tails. In contrast, unstable
SIDER2-bearing transcripts are degraded via a mecha-
nism that seems to be deadenylation independent.
Nucleic Acids Research, 2010, Vol.38, No. 17 5871Figure 1. The second highly conserved 79-nt signature sequence amongst SIDER2 retroposons is essential for mRNA degradation. (A) Sequence
alignment of two selected SIDER2 sequences present in the 30-UTRs of L. major LmjF36.3810 (3810) and LmjF08.1270 (1270) transcripts
using the multiple sequence alignment program multialin (http://bioinfo.genotoul.fr/multalin/multalin.html). Conserved motifs within SIDER2
retroposons, including the thymidine-rich stretch, the two tandemly repeated signatures I and II at the 50-end of SIDER2, and the adenosine-rich
stretch at the 30-end are highlighted. (B) Schematic representation of the chimeric luciferase (LUC) constructs tested and their corresponding names.
The full-length 30-UTR of 3810 (30-UTR3810), a 30-UTR lacking both conserved signatures (30-UTR381079I+II), a 30-UTR lacking either the ﬁrst
(30-UTR381079I) or the second (30-UTR381079II) signature and a 30-UTR lacking the last 80nt of SIDER3810 (30-UTR381080) were placed
downstream of the LUC reporter gene. The entire SIDER2 element or its truncated forms are illustrated as grey boxes. The plasmid LUC-IR,
containing the IR of 3810 served as a control. LUC activity was measured in the diﬀerent transfectants (middle panel). Fold diﬀerences in LUC
activity were normalized with plasmid copy numbers (Supplementary Table S2) and the values indicated are relative to the LUC-IR control.
Numbers in bold correspond to the relative fold changes compared to the full-length 30-UTR3810. Each bar and value represents the mean and
standard deviations of four independent experiments. Northern and western blot analyses of total RNA and protein extracts from recombinant
L. major promastigotes were carried out using LUC-speciﬁc probes and antibodies (right panels). Expression levels (mRNA and protein) of the NEO
marker present on all plasmids served as a control for loading and for determining diﬀerences in plasmid copy numbers. Signal intensities were
quantiﬁed and normalized with respect to the loading controls and plasmid copy numbers.
5872 Nucleic Acids Research, 2010, Vol.38, No. 17Figure 2. Rapid degradation of unstable SIDER2-bearing transcripts is not initiated by a shortening of the poly(A) tail. (A) Schematic represen-
tation of the deadenylation assay. LUC transcripts are speciﬁcally cleaved at 300nt from the poly(A) tail using oligonucleotide-directed RNase H
cleavage. The resulting 30-products containing the poly(A) tail are visualized by northern blot using a probe complementary to the last 300nt of
transcripts 3810 and 1270, respectively. Poly(A) tail lengths of chimeric LUC transcripts were analyzed at diﬀerent time points after transcriptional
arrest using ActD. In each experiment, one sample was treated with oligo(dT) and served as a control for a completely deadenylated mRNA species.
Another RNA sample that was not treated with RNase H was used as negative control. Deadenylation proﬁles of the unstable SIDER2-containing
transcripts (B) LUC-30-UTR3810 and (C) LUC-30-UTR1270 and of stable LUC chimeric mRNAs lacking either the complete (D) SIDER3810 or
(E) signature II. Histone 4A mRNA was used as a loading control together with an ethidium bromide staining to visualize rRNA. Decay kinetics of
the corresponding uncut LUC mRNAs (from identical samples) and their half-lives (t1/2) are shown below the blots to demonstrate the fate of the
full-length LUC transcripts (uncut) in comparison to the cleaved 30-ends including the poly(A) tails. LUC mRNA levels were normalized to those of
the a-tubulin mRNA. The numbers indicated below the blots represent the relative LUC transcript abundance with respect to time point 0 (before
addition of the transcription inhibitor Act D). Deadenylation assays shown here are representative of three independent experiments that yielded
similar results.
Nucleic Acids Research, 2010, Vol.38, No. 17 5873SIDER2-mediated mRNA degradation is initiated by a
site-speciﬁc endonucleolytic cleavage within the
cis-acting signature II sequence
Deadenylation-independent mechanisms of mRNA deg-
radation in eukaryotes are rare and have been described
so far only in yeast and mammalian cells. Such mechan-
isms initiate either by deadenylation-independent
decapping or through cleavage by an endoribonuclease
within a speciﬁc 30-UTR sequence, which often leads to
a rapid destruction of the remaining mRNA body by
exoribonucleases (27–29). Although decapping activities
have been described in trypanosome extracts (9), no
genes encoding decapping enzymes could be identiﬁed in
the genome of L. major (10). Therefore, we examined the
possibility that rapid decay of SIDER2-containing
mRNAs is initiated through endonucleolytic cleavage.
We failed detecting cleavage products by northern
blotting for the endogenous transcripts 1270 and 3810,
but these are of low abundance. Hence, to increase the
possibility of detecting in vivo cleavage products, we per-
formed RPAs using chimeric LUC reporter transcripts ex-
pressed at higher levels from episomal vectors. Total RNA
isolated from either L. major wild-type cells or from six
L. major LUC transgenic cell lines (LUC-30-UTR1270,
LUC-30-UTR127079I+II, LUC-30-UTR3810, LUC-30-
UTR381079I+II, LUC-30-UTR381079I and LUC-30-
UTR381079II) was independently incubated with
in vitro-transcribed radiolabeled anti-sense RNA probes
of diﬀerent sizes complementary to the SIDER2 element
in transcripts 3810 and 1270, and then subjected to RNase
A/T1 treatment. Protected double-stranded RNA
products were resolved on an 8% polyacrylamide urea
gel and visualized by autoradiography.
First, using RNA extracted from the LUC-30-UTR3810
transfectant and a radiolabeled anti-sense RNA probe
complementary to the ﬁrst 400nt of SIDER3810, we
observed, in addition to the uncleaved protected 400-nt
fragment, four smaller RNA products (Figure 3A;
marked with asterisks). Fragment A ( 90nt) is generated
after cleavage at the beginning of signature II (cleavage
A/B). The large product (310nt; fragment B) derived from
this cleavage was not detected, but instead, three frag-
ments of 45, 140 and 260nt were seen, indicating a
second cleavage within signature II at  50-nt downstream
of the ﬁrst cleavage site (cleavage C/E; Figure 3A and B)
(181–192nt; Figure 1A). The 140- and 260-nt products
add up to the size of the full-length SIDER3810 probe
(400nt) and are generated from a single cleavage
reaction at the second site. The absence of the 310-nt
cleavage fragment (ﬁrst cleavage) together with the
higher intensity of the 140 and 260-nt products (second
cleavage) suggest that the second cleavage is more
prominant. Deletion of signature I, shown to not alter
mRNA decay (Figure 1B), seems to favor cleavage at
the ﬁrst position, as only the fragment of  310nt
(fragment G) was protected in the LUC-30-
UTR381079I mRNA (Figure 3A and B). Structural
changes between these reporter mRNAs might explain dif-
ferences in cleavage. In agreement with our deletion data
demonstrating that signature II is essential for mRNA
degradation (Figure 1B), RPA analysis of LUC-30-
UTR381079I+II and LUC-30-UTR381079II mRNAs
lacking either both signatures I and II or only signature
II indicated no cleavage. Only a protected fragment of
 220nt corresponding to the size of the truncated
SIDER3810 (fragment F) was detected. In the case of
LUC-30-UTR381079II mRNA, an additional product
of  90nt corresponding to signature I was detected
(Figure 3A and B). This is the result of a ss cleavage due
to a looping of the SIDER3810 probe at the position of
the target RNA where signature II was deleted.
Furthermore, cleavage within signature II was con-
ﬁrmed by RPA using a distinct SIDER2 retroposon
element, SIDER1270, which is part of the 30-UTR of tran-
script 1270 sharing a  60% overall sequence identity with
SIDER3810 (Figure 1A). Using total RNA extracted from
L. major LUC-30-UTR1270, we detected in addition to the
protected 480-nt uncleaved fragment, two major
RNA-protected products of  120 and  360nt (marked
with asterisks) whose sizes add up to the full-length
RNA probe (480nt) (Supplementary Figure S3A). These
results are in agreement with cleavage at the beginning of
signature II, as it was also shown for LUC-30-UTR3810
mRNA (Figure 3). However, in the case of LUC-30-
UTR1270 mRNA, we did not detect any secondary
clevage. Interestingly, no cleavage products were
observed when using LUC-30-UTR127079I+II mRNA
lacking both signature sequences and a single fragment
of  260nt corresponding to the truncated SIDER1270
was protected from RNase treatment (Supplementary
Figure S3A and B). This is a strong indication that these
RNA intermediates are the products of an
endoribonuclease activity and not of exoribonuclease
pause sites at stable secondary structures (30). In order
to distinguish the protected full-length fragments from un-
digested probe remaining in the sample, we used a 600-nt
probe that is longer than the target RNA. This probe is
complementary to the ﬁrst 480nt of the SIDER1270 sense
RNA but contains an extension of 68nt at the 50-end and
of 59nt at the 30-end originating from the plasmid vector
(see Supplementary Figure S3C and ‘Materials and
methods’ section). The longer probe detected the same
protected RNA bands (Supplementary Figure S3B and
C) than the fully complementary 480-nt probe
(Supplementary Figure S3B and C), hence conﬁrming
the speciﬁcity of the protected uncleaved RNAs. RPAs
have been optimized in order to minimize possible
overdigestion by RNases, and all our control experiments
support a speciﬁc cleavage. Indeed, no cleavage products
were detected with the stabilized truncated RNAs (LUC-
30-UTR127079I+II, LUC-30-UTR381079I+II and
LUC-30-UTR381079II) (Figure 3; Supplementary
Figure S3). Furthermore, cleavage intermediates were
only seen with the full-length LUC-30-UTR1270 mRNA
and were not detected in the control lanes containing wild
type or yeast RNA treated or untreated with RNases.
To map more precisely the putative cleavage site(s)
within signature II and to conﬁrm endonucleolytic
cleavage by another method, LUC-30-UTR3810 RNA
samples were subjected to primer extension analysis. For
this, ﬁve diﬀerent reverse primers (P1–P5) complementary
5874 Nucleic Acids Research, 2010, Vol.38, No. 17to a region between 100 and 200nt downstream of the
putative cleavage sites in SIDER3810 were designed
(Figure 4A; Supplementary Table S1). To visualize
speciﬁc cleavage products, the primers were
50-end-labeled, annealed to total RNA isolated from the
L. major LUC-30-UTR3810 transfectant and extended via
reverse transcription. The size of the generated cDNA
fragments should correspond to the number of nucleotides
between the labeled primer and the 50-end of the cleaved
RNA where reverse transcriptase falls of its template.
Primer extension with all ﬁve primers produced in each
case two speciﬁc extended fragments (1 and 2; marked
with asterisks). The sizes of these fragments (Figure 4A
and B) were in agreement with the RNase protection
results (Figure 3) and conﬁrmed the occurrence of two
distinct cleavage events within SIDER3810 signature II.
Using a dideoxy-sequencing strategy with primer P1
(Figure 4C), we mapped the ﬁrst cleavage site between
an AU dinucleotide surrounded by a C-rich motif
(position 116-117 in Figure 4A) and the second cleavage
site possibly between a CU (or a UA) dinucleotide at 50-nt
downstream (position 164-166 in Figure 4A, C and D).
Figure 3. Detection of in vivo-generated cleavage products derived from SIDER2-containing mRNAs by RPAs. (A) Total RNA was isolated from
L. major wild-type cells (WT), the recombinant L. major expressing a chimeric LUC transcript carrying the full-length 30-UTR of 3810 (LUC-30-
UTR3810) and the truncated mutants LUC-30-UTR381079I+II, LUC-30-UTR381079I and LUC-30-UTR381079II lacking either both signatures
(I+II) or only signature I or signature II, respectively. These RNAs were independently mixed with an in vitro-transcribed radiolabeled anti-sense
SIDER3810 probe of 400nt and thereafter subjected to RNase A/T1 treatment. Wild-type RNA and yeast RNA with (negative control) or without
RNase treatment (positive control) were used as controls. A 30-labeled RNA ladder was used to estimate the size of the fragments (M). (B) Schematic
representation of the in vivo cleaved (unstable LUC-30-UTR3810 and LUC-30-UTR381079I) and uncleaved (stabilized LUC-30-UTR381079I+II
and LUC-30-UTR381079II) SIDER2-containing mRNAs. The sizes of the observed cleavage products suggest that a ﬁrst cleavage occurs at the
beginning of SIDER3810 signature II (cleavage A/B) and that a second, more dominant, cleavage occurs at  50-nt downstream (cleavage C/E). In
addition to the full-length protected band (400nt), four cleavage products of  260,  140,  90 and  45nt (indicated with asterisks) were detected
from the LUC-30-UTR3810 mRNA. The cleavage products of 260 and 140nt correspond to the second cleavage and the 90-nt fragment to the ﬁrst
cleavage (the expected 310-nt fragment is not visible in this experiment, as it was further cleaved at the second position to generate the 45- and 260-nt
fragments). The band observed between the cleavage fragments C and E in the LUC-30-UTR3810 lane was not reproducible in the other experiments.
In all cases, cleavage products sum up to the size of the full-length SIDER3810 probe (400nt). In the truncated LUC-30-UTR381079I
mRNA-lacking signature I, only the ﬁrst cleavage site was detected, as a single fragment of  310nt was protected. In the case of LUC-30-
UTR381079II mRNA-lacking signature II, two cleavage fragments of 90 and 220nt were detected, as expected, given that RNases could digest
the ss region of the probe corresponding to signature II. Deletion of both signatures in LUC-30-UTR381079I+II mRNA produced a 220-nt
RNase-resistant fragment, as expected. The data shown here are representative of three independent experiments that generated the same RNase
digestion patterns.
Nucleic Acids Research, 2010, Vol.38, No. 17 5875Preliminary data using two diﬀerent primers conﬁrmed
the occurrence of a major cleavage within the AU di-
nucleotide also for LUC-30-UTR1270 mRNA (data not
shown).
To further characterize endogenous cleavage products
derived from SIDER2-bearing mRNAs, we used an RNA
circularization and sequecing strategy referred to as
reverse ligation-mediated PCR (RL-PCR) (26,31). Most
endoribonucleases generate 50-phosphate and 30-hydroxyl
termini after RNA cleavage, which can be ligated using T4
RNase ligase (31). In order to characterize the ends of the
in vivo endonucleolytic cleavage products, total RNA
from the L. major LUC-30-UTR1270 transfectant was
incubated with T4 ss RNA ligase at low concentrations
that favor the ligation of ends from the same molecule,
thereby generating circular RNAs. In our case, the
cleavage sites (50-end) should be joined directly to their
poly(A)-tails (30-end) (Supplementary Figure S4A). The
full-length LUC-30-UTR1270 transcript cannot be
ligated, because it is capped at its 50-end (Supplementary
Figure S4A). Identical RNA samples without addition of
T4 ssRNA ligase served as a negative control. After
ligation, the 50–30 junction was reversed transcribed
using primer P5 and then PCR-ampliﬁed with the
primer pair P5/P2 (Supplementary Figure S4A and B;
Supplementary Table S1). Due to the low abundance of
endonucleolytic cleavage products, a nested PCR using
the internal primers P6/P2 was performed
(Supplementary Figure S4A and C; Supplementary
Table S1). The results of the nested PCR using two diﬀer-
ent concentrations of total RNA (a=20mg; b=40mg)
are shown in Supplementary Figure S4C. Ampliﬁcation
products without poly (A)-tail were predicted to be
 90-bp long. All fragments within the expected size
range (between 75 and 200bp; marked with an asterisk)
that were absent in the control lanes without ligase or
reverse transcriptase were excised from the gel, puriﬁed,
cloned and sequenced. A sequence alignment of nine
unique clones (Supplementary Figure S4D) revealed that
most PCR-products exhibit relatively short poly(A)-tails
( 10nt) at the expected polyadenylation site. The detec-
tion of unusually short poly(A)-tails using the RL-PCR
method was reported before (26,32) and is attributed to an
intrinsic bias of this method against longer poly(A)-tails,
which is further increased when nested PCR and cloning
procedures are included. Interestingly, in the longest PCR
fragment, poly(A)-tail was ligated with a T at the second
TCCCCT repeat (Figure 1A), which corresponds to the
ﬁrst cleavage site between an AU dinucleotide
(Supplementary Figure S4D), a region predicted also by
Figure 4. Mapping of the cleavage site(s) in a SIDER2-containing mRNA by primer extension analysis. (A) Nucleotide sequence of SIDER3810
retroposon with signature I (black box) and II (grey box) sequences highlighted, and the ﬁve primers (P1–P5) indicated by arrows. The sizes of the
expected primer extension products with full-length LUC-30-UTR3810 mRNA, depending on whether cleavage occurs at the ﬁrst (Cl1) or the second
(Cl2) site within signature II, are listed below. (B) Primer extension assay with total RNA isolated from L. major LUC-30-UTR3810 transfectant
using ﬁve diﬀerent reverse primers P1–P5 (Supplementary Table S1). Two speciﬁc extension fragments were obtained with each of the primers
(indicated with blue asterisks) corresponding to both cleavages (1 and 2). Their sizes estimated with a radiolabeled DNA marker (M) are in
agreement with the predicted cleavage regions. (C) A dideoxy-sequencing and primer extension with primer P1 allowed a precise mapping of the
cleavage sites between an AU dinucleotide (cleavage 1) and a CU (or a UA; it is not easy to distinguish from the sequencing data) dinucleotide
(cleavage 2) marked with a red arrow. (D) Reverse complement sequence (the black arrow indicates where the highlighted sequence starts) and the
corresponding sequence of SIDER3810 RNA. Cleavage sites 1 and 2 are indicated with an arrow. The data shown here are representative of four
independent experiments with similar results.
5876 Nucleic Acids Research, 2010, Vol.38, No. 17primer extension (Figure 4; data not shown) and RPA
(Figure 3; Supplementary Figure S3). The presence of
other shorter fragments is expected, and indicates that
the cleavage products may be subjected to rapid degrad-
ation by 50–30 exonucleases. No RNA-ligation products
containing sequences beyond the predicted C-rich
cleavage site were identiﬁed.
Interestingly, in vivo-generated 50- and 30-cleavage
products were also detected by northern blotting.
Northern blot hybridization is a less sensitive assay than
RPA and primer extension, but represents the most
reliable way to detect the cleavage fragments in vivo.
DNA probes recognizing either the full-length 30-UTR
of transcript 3810 or the whole SIDER3810 sequence or
the last 300nt of the 3810 30-UTR detected a fragment of
 1.2kb corresponding to the predicted 30-cleavage
product at the level of signature II from LUC-30-
UTR3810 mRNA (Figure 5A). The 50-cleavage fragment
( 2.5kb) was not detected with the 30-UTR3810 or the
LUC speciﬁc probes (Figure 5A), however, possibly
because it was rapidly degraded by exonucleases. In the
case of the LUC-30-UTR1270 mRNA, a fragment of
 2.7kb corresponding to the expected 50-cleavage
product was detected by probes recognizing either the
full-length 1270 30-UTR or the LUC gene (Figure 5B).
The 1270 30-UTR probe failed to detect the corresponding
30-cleavage fragment of  0.6kb (Figure 5B), most likely
due to the low abundance and faster exonucleolytic diges-
tion of this smaller fragment. In agreement with our RPA
and primer extension data, 50-o r3 0-cleavage products
were absent in the stabilized RNAs lacking signature II
(LUC-30-UTR381079II and LUC-30-UTR127079I+II)
(Figure 5A and B). In addition, we have been able to
detect 50- and 30-cleavage products by northern blotting
in RNA preparations from another set of L. major trans-
fectants expressing myc-tagged full-length 1270 and 3810
mRNAs (Supplementary Figure S5). In this experiment,
both the 50- and 30-cleavage fragments derived from
3810ORFmyc-30-UTR ( 2.0 and  1.2kb) and
1270ORFmyc-30-UTR ( 2.0 and  0.6kb) mRNAs were
detected by the full-length 30-UTR probes. In summary,
speciﬁc endonucleolytic cleavage products were detected
Figure 5. Detection of in vivo-generated endonucleolytic cleavage products from reporter mRNAs harboring distinct SIDER2 retroposon elements
by northern blotting. (A) Northern blots of total RNA from recombinant L. major LUC-30-UTR3810 (LUC reporter gene under the control of the
full-length 30-UTR of transcripts 3810) and LUC-30-UTR381079II (30-UTR of 3810 lacking the SIDER2 signature II sequence) hybridized with
four diﬀerent DNA probes corresponding to the complete 30-UTR3810 (left panel), the SIDER3810 sequence alone, the last 300nt of the 3810 30-
UTR (middle panels) or the LUC gene (right panel). The full-length 30-UTR3810, SIDER3810 and 300–3810 probes recognized a band of  1.2kb,
which corresponds to the expected 30-cleavage product (indicated by a red arrow; see also schematic representation above the blots). This band is
absent in the control RNA-lacking signature II (cleavage region). The 50-cleavage fragment was not detected under these conditions using either the
full-length 30-UTR3810 or the LUC-speciﬁc probes. (B) Northern blots of total RNA from L. major transfectants LUC-30-UTR1270 (LUC reporter
gene under the control of the full-length 30-UTR of transcripts 1270) and LUC-30-UTR127079I+II (30-UTR of 1270 lacking both signatures I and
II) hybridized with two diﬀerent DNA probes speciﬁc for LUC (left panel) and the 30-UTR1270 (right panel). Both probes detected a band of
 2.7kb corresponding to the expected size of the 50-cleavage product (indicated by a red arrow; see schematic representation above the blots), which
is absent in the control RNA-lacking signatures I+II (cleavage region). The 30-cleavage fragment was not detected under these conditions. Northern
blots shown here are representative of three independent experiments yielding similar results. Expression levels of the NEO mRNA present on all
plasmids served as a control for loading and for evaluating diﬀerences in plasmid copy numbers between the transfectants.
Nucleic Acids Research, 2010, Vol.38, No. 17 5877from several distinct SIDER2-bearing mRNAs using four
independent methods, only when the regulatory
cis-acting region located within signature II was present.
Altogether, these data support that decay of SIDER2-
containing mRNAs is initiated by a site-speciﬁc
endonucleolytic cleavage at the beginning of the conserved
signature II sequence (137–147nt; Figure 1A).
SIDER2 anti-sense RNA complementary to
the endonucleolytic cleavage region protects
SIDER2-containing transcripts from rapid degradation
It is intringuing that while the vast majority of SIDER2
retroposons located in 30-UTRs follows the direction of
transcription, most of SIDER2 elements located in IRs are
inserted in the opposite orientation relative to transcrip-
tion (21). Moreover, SIDER2 elements were found in the
anti-sense orientation of Leishmania directional gene
clusters (21). Given that anti-sense transcription has pre-
viously been reported in Leishmania (2,33), we explored
the possibility that SIDER2 anti-sense RNAs are natur-
ally produced in this parasite. Strand-speciﬁc RT-PCR
experiments conﬁrmed indeed the presence of such RNA
products (M. Mu ¨ ller et al., in revision; P.K.
Padmanabhan, unpublished data). Hence, it was import-
ant to test whether SIDER2 anti-sense RNA could alter
SIDER2-mediated mRNA degradation. To directly
address this question, we ﬁrst generated a series of trans-
genic L. major cell lines ectopically expressing either sense
or anti-sense SIDER1270 and SIDER3810 RNAs
(Figure 6A). As estimated by Southern blot analysis, the
copy number of sense and anti-sense SIDER2-expressing
vectors was comparable (Supplementary Table S2).
Northern blots using SIDER2-speciﬁc probes conﬁrmed
that the ectopically provided SIDER2 RNAs were correct-
ly processed and that were in average 6–10-fold more
abundant than the endogenous transcripts 1270 and
3810, respectively (data not shown). Overexpression of
sense SIDER1270 or SIDER3810 RNAs did not alter
steady-state levels of the endogenous transcripts 1270
and 3810 (Figure 6B). In contrast, overexpression of an
anti-sense RNA fully complementary to the SIDER2
sequence of transcripts 1270 or 3810 signiﬁcantly
increased accumulation of the latter by 2.14- and
2.64-fold, respectively (Figure 6B). Interestingly, even a
heterologous anti-sense RNA (SIDER1270as) sharing
high sequence similarity with the mapped SIDER3810
cleavage region (76% sequence identity; Figures 1A
and 4) signiﬁcantly increased accumulation of the en-
dogenous transcript 3810 (Figure 6B).
To investigate how a SIDER2 anti-sense RNA can
interfere with the rapid decay of SIDER2-bearing tran-
scripts, we generated L. major transgenic lines co-
expressing LUC reporter constructs with either the
full-length 30-UTR1270 and SIDER3810 anti-sense RNA
or the 30-UTR3810 and SIDER1270 anti-sense RNA, as
illustrated in Figure 7A. Expression and correct process-
ing of SIDER2 anti-sense transcripts in the double trans-
fectants was veriﬁed using strand-speciﬁc riboprobes
(Figure 7B, middle panel) and RPAs (data not shown).
Similarly to the single transfectants overexpressing only
SIDER2 anti-sense RNA (Figure 6B), the steady-state
levels of LUC-30-UTR1270 and LUC-30-UTR3810 tran-
scripts were increased by 4.6- and 5.9-fold, respectively,
in the double transfectants (Figure 7B). LUC protein
levels were in accordance with LUC mRNA levels
(Figure 7C). Higher accumulation of LUC-30-UTR3810
mRNA in the presence of SIDER3810 anti-sense RNA
was due to a 3-fold increase in mRNA stability (75min
versus >200min; Figure 7D, three lower panels).
Moreover, decay of the stabilized LUC-30-UTR3810 tran-
script in the presence of SIDER3810 anti-sense RNA was
initiated by poly(A)-tail shortening (Figure 7D, two upper
panels), similarly to the non-regulated stable mRNAs
(Figure 2), suggesting that an RNA complementary to
SIDER2 sequences can interfere with the mechanism by
which SIDER2-containing transcripts are normally
degraded. As vectors harboring SIDER2 anti-sense
RNA were generally  2-fold less expressed ( 2-fold less
copies; Supplementary Table S2) than the reporter
SIDER2 sense vectors in the double transfectants, we
can exclude the possibility that mRNA stabilization is
simply due to a sequestration of putative trans-acting
factor(s) that might also bind to SIDER2 anti-sense RNA.
To address whether an interaction between sense and
anti-sense RNA at the endonucleolytic cleavage site con-
tributes to the blockade of SIDER2-mediated mRNA
Figure 6. Ectopic expression of SIDER2 anti-sense RNA results in an
increased accumulation of endogenous L. major SIDER2-containing
transcripts. (A) Schematic representation of plasmids overexpressing
SIDER2 in both orientations. SIDER2 sequences from transcripts
1270 or 3810 were cloned downstream of a NEO selection marker in
the sense (s) or anti-sense (as) orientation and stably transfected into
L. major wild-type cells (WT). aIR refers to the IR of the a-tubulin
gene necessary for NEO mRNA processing. (B) Northern blot analysis
with total RNA from L. major WT and transfectants. The endogenous
transcripts 1270 or 3810 were detected with probes speciﬁc to the
coding regions of 1270 (left panel) and 3810 (right panel). The copy
number of the SIDER2 expression plasmids was estimated by Southern
blot as indicated in Supplementary Table S2. The signal intensities were
quantiﬁed and the mRNA abundance was normalized to a-tubulin
mRNA and calculated with respect to WT mRNA levels.
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anti-sense RNA lacking the second signature sequence,
shown here to be essential for mRNA degradation
and cleavage (Figures 1B, 2–5 and Supplementary
Figure S3). As illustrated in Figure 7E (left panel),
overexpression of SIDER3810 anti-sense RNA lacking
signature II (LUC-SIDER381079IIas) failed to block
degradation of LUC-30-UTR3810 mRNA. Interestingly,
overexpression of a heterologous anti-sense RNA
(SIDER3810as) resulted in >5-fold accumulation of the
LUC-30-UTR1270 mRNA (Figure 7E, right panel), simi-
larly to the eﬀect seen with the homologous SIDER1270
anti-sense RNA (Figure 7B). In summary, these results
suggest that SIDER2-bearing transcripts can be protected
from degradation by anti-sense RNA, probably through
base-pairing to a ss region within the cis-acting signature
II sequence.
DISCUSSION
This article provides new insights into the underlying
decay mechanism of unstable Leishmania transcripts
involving extinct SIDER2 retroposons predominantly
located within 30-UTRs. We have provided evidence that
(i) the second 79-nt signature, which is the most conserved
sequence amongst SIDER2 retropososons (18,21) is the
cis-acting element conferring degradation of SIDER2-
bearing mRNAs; (ii) rapid turnover of SIDER2-
containing transcripts is deadenylation-independent, as
opposed to stable transcripts which are degraded
through a progressive shortening of poly(A) tails; (iii)
SIDER2-mediated decay is initiated by a site-speciﬁc
endonucleolytic cleavage within the second 79-nt signature
sequence, which is essential for degradation and (iv)
endonucleolytic cleavage and subsequent rapid mRNA
Figure 7. SIDER2 anti-sense RNA complementary to the cleavage region blocks degradation of unstable SIDER2-containing reporter transcripts.
(A) Schematic representation of the chimeric LUC reporter constructs bearing either a sense (s) or anti-sense (as) SIDER2 retroposon from tran-
scripts 1270 or 3810. Pairs of sense/anti-sense vectors LUC-30-UTR1270/SIDER1270as LUC-30-UTR3810/SIDER3810as, LUC-30-UTR3810/
SIDER381079IIas and 30-UTR1270/SIDER3810as were co-transfected into L. major. The plasmids expressing the full-length 30-UTRs of 3810
and 1270 cloned downstream of the LUC gene harbor a neomycin phosphotransferase (NEO) gene as a selection marker. Anti-sense SIDER2
sequences were inserted downstream of a hygromycin B (HYG) selection marker. Arrows indicate the orientation of SIDER2 elements. Y corres-
ponds to a 92-bp polypyrimidine stretch (34) and a-IR refers to the IR of a-tubulin, both necessary for NEO, HYG and SIDER2as RNA processing.
(B) Northern blot analysis to compare LUC mRNA expression levels in single ( ) and double (+) transfectants using a LUC-speciﬁc probe.
Expression and correct processing of both fully complementary anti-sense SIDER2 transcripts (1270as and 3810as) was veriﬁed with riboprobes
speciﬁc to each SIDER2 sequence. Their sizes of  1.2kb indicate that the transcripts are spliced within the a-IR and do not contain HYG sequences.
The LUC signal intensities were normalized with a-tubulin mRNA levels and calculated with respect to the LUC-plasmid copy numbers
(Supplementary Table S2). (C) Western blot analysis using L. major protein lysates and a LUC-speciﬁc antibody. Protein loading was controlled
with an anti-a-tubulin antibody. (D) Deadenylation proﬁle and decay kinetics in single (LUC-30-UTR3810) and double L. major transfectants
(LUC-30-UTR3810/SIDER3810as) as determined by northern blotting (identical samples). The numbers below the blots represent the relative
LUC mRNA levels with respect to time point 0 (before addition of ActD). Histone 4A was used as a loading control. The mRNA half-lives of
the uncut LUC transcripts are shown below the blots. (E) Northern blot hybridization to evaluate LUC-30-UTR3810 mRNA accumulation in the
absence or presence of a truncated SIDER3810 anti-sense RNA-lacking signature II (SIDER381079IIas) (left panel). Northern blot analysis to
compare LUC-30-UTR1270 mRNA abundance in the presence or absence of a heterologous SIDER3810 anti-sense RNA (right panel). SIDER3810
and SIDER1270 retroposons share a 76.5% sequence identity at the level of signature II and >80% identity within the cleavage site (Figure 1A).
LUC signal intensities were normalized as indicated in (B).
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plementary to the cleavage site. These are original ﬁndings
that establish a new paradigm for how short-lived
mRNAs in Leishmania sharing a conserved retroposon
signature sequence in their 30-UTRs are degraded, and
could serve as the basis for a better understanding of
mRNA decay pathways not only in protozoan parasites
but in general.
Our ﬁnding that the conserved signature II sequence of
SIDER2 retroposons is essential for endonucleolytic
cleavage and rapid mRNA decay provides also further
explanations regarding the evolutionary divergence of
SIDER1 and SIDER2 subfamilies to fulﬁll distinct bio-
logical functions. It is remarkable that SIDER1
retroposons, which have been associated with translation-
al control rather than mRNA turnover (22,23) lack signa-
ture II (18,21). The fact that deletion of the ﬁrst signature
from SIDER2 did not change the fate of mRNA degrad-
ation is consistent with this hypothesis. Interestingly,
analysis of the predicted secondary structure of selected
SIDER2 retroposons using the RNAstructure program
(35) indicated that the structure of signature II remained
unchanged upon deletion of signature I (data not shown).
A multiple sequence alignment of most Leishmania
SIDER2 retroposons demonstrated that signature II is
signiﬁcantly more conserved than signature I (21). The
high conservation of signature II sequences together
with the remarkable expansion of SIDER2 elements
throughout the Leishmania genome (>1300 copies) (21)
and their proven involvement in mRNA decay suggest
that a large number of Leishmania SIDER2-bearing tran-
scripts may be under the same regulatory control. Several
SIDER2-containing transcripts in Leishmania are
short-lived (18) and/or diﬀerentially expressed in either
life stage of the parasite (36) or preponderantly enriched
among transcripts encoding metabolic functions (21).
Therefore, it is possible that targeting of selected subsets
of SIDER2-bearing transcripts for rapid degradation
could permit their co-ordinated regulation in response to
environmental changes throughout the digenetic life cycle
of the parasite. Interestingly, the existence of post-
transcriptional regulons has recently been reported in
the related species T. brucei (37–40).
A major outcome of this experiment is the demonstra-
tion that rapid turnover of unstable SIDER2-containing
mRNAs is initiated by a novel mechanism, which is
deadenylation independent and involves a site-speciﬁc
endonucleolytic cleavage. This is in sharp contrast to
stable mRNAs in Leishmania lacking SIDER2 or
carrying a truncated SIDER2 without signature II,
which are degraded after progressive deadenylation, as it
is the case for most yeast and mammalian mRNAs (6).
Endonucleolytic digestion products from SIDER2-bearing
mRNAs were detected in vivo by four diﬀerent methods
(e.g. RNase protection, primer extension, reverse
ligation-mediated PCR and northern blotting) using
distinct SIDER2 RNA substrates and a large number of
test and control RNAs, which provided further support
for the signiﬁcance of endonucleolytic cleavage. Primer
extension and reverse ligation-mediated PCR analyses
indicated a preferential cleavage of N–pyrimidine (AU)
or pyrimidine–pyrimidine (CU) bonds. The most preva-
lent endonucleolytic cleavage site was mapped between
an AU dinucleotide ﬂanked by a 50-UCCCC-30 duplicated
motif at the 50-extremity of the conserved 79-nt signature
II sequence. However, in the case of LUC-30-UTR3810
mRNA, we have detected a secondary predominant
cleavage at  50-nt downstream the AU dinucleotide.
This cleavage was also seen with the endogenous tran-
script 3810 (data not shown), suggesting that although
the primary sequence of the putative cleavage site(s) is
highly conserved, changes in the overall RNA secondary
structure between the diﬀerent SIDER2 elements might
favor additional cleavages. The importance of these se-
quences for mRNA decay via endonucleolytic cleavage
was further supported by deletion analysis, as removal
of signature II from SIDER2 completely abolished
cleavage, and turnover of the truncated stabilized RNAs
was now initiated by deadenylation. Hence, combined
data from diﬀerent experimental approaches support
that a site-speciﬁc endonucleolytic cleavage of
SIDER2-bearing transcripts initiates their rapid degrad-
ation. Moreover, it is highly unlikely that the observed
cleavages occur through spontaneous hydrolysis on hyper-
sensitive sites after RNA was extracted from the cell. In
this case and in the absence of RNases in the RNA
sample, one would expect to detect equal amounts of the
50- and 30-cleavage fragments by northern blotting whose
accumulation increased with time. However, in our experi-
ments, either only one of the expected cleavage fragments
was detected (Figure 5) or when both were visible in the
blots, they were not equally abundant (Supplementary
Figure S5) and did not exponentially accumulate with
time (data not shown). This further argues for an in vivo
cleavage of the RNAs (followed possibly by exonuclease
activities) rather than an ex vivo RNA hydrolysis of
phosphodiester bonds in RNA.
We favor a model of an endonucleolytic cleavage
mediated through the action of an endoribonuclease.
This model is supported by initial studies using general
inhibitors of translation, e.g. puromycin and
cycloheximide, that demonstrated a gradual increase in
the half-lives of SIDER2-containing transcripts, but not
of those lacking SIDER2 (data not shown) upon transla-
tional arrest, suggesting the action of a short-lived
endoribonuclease. In addition, the circularization of
SIDER2 cleavage products using T4 ssRNA ligase
suggests that they exhibited 50-monophosphate and
30-hydroxyl ends, which are usually generated through
the action of ribonucleases. However, catalytic RNAs
can also generate 50-phophate and 30-hydroxyl as
cleavage products, and at this point we cannot completely
rule out the possibility that enzymatic cleavage requires an
RNA co-factor as is the case of RNase P (41) and the
eukaryotic RNase P MRP ribonucleases (42), but
homologs of these enzymes are not encoded by the
Leishmania genome. To date, only a few
endoribonucleases, shown to cleave mRNAs in higher eu-
karyotes, have been indentiﬁed. These include PMR1, an
estrogen-regulated polysomal endoribonuclease that de-
stabilizes serum protein mRNAs (43), the Ras
GTPase-activating protein-binding protein (G3BP) that
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erythroid-enriched endoribonuclease (ErEN) involved in
 -globin mRNA turnover (28), the inositol-requiring
enzyme-1 (IRE1) that mediates rapid degradation of
endoplasmic reticulum-localized mRNAs during the
unfolded protein response (45), the mRNA processing
endoribonuclease, which degrades mRNAs involved in
the cell cycle regulation in Saccharomyces cerevisiae (46)
and the RNAi components Dicer (47) and Argonaute 2
(48). Rrp44, a component of eukaryotic exosome (49,50),
and SMG6, a protein involved in non-sense-mediated
decay pathway (51) also possess an endonucleolytic
activity. The potentially retrotransposition competent
ingi and L1Tc elements from which SIDERs have appar-
ently derived (21,52) encode a large protein containing the
N-terminal apurinic/apyrimidinic-like endonuclease
(APE), the reverse transcriptase, the RNase H and the
C-terminal DNA-binding domains (19). A homolog of
APE-type endonucleases encoded by all non-LTR retro-
transposons (53) is present in the genome of Leishmania.
Interestingly, APE1 was reported recently to cleave the
coding region determinant of c-myc mRNA (54).
However, to fully understand the mechanism and signiﬁ-
cance of endonucleolytic cleavage in the control of
SIDER2-mediated mRNA decay, the responsible
endoribonuclease must be identiﬁed and work in that dir-
ection is currently being pursued in our laboratory.
In this article, we also provide experimental evidence
supporting a potential role of anti-sense RNA in prevent-
ing or altering rapid turnover of endogenous and reporter
SIDER2-bearing mRNAs. We show that ectopically ex-
pressed SIDER2 anti-sense RNA targeting either the
SIDER2-containing endogenous transcripts 3810 and
1270 or reporter transcripts harboring SIDER3810
and SIDER1270 elements in their 30-UTR can protect
these RNAs from endonucleolytic cleavage and
deadenylation-independent decay, and consequently
increase their half-lives. One plausible explanation of
how anti-sense RNA could block mRNA degradation is
through base-pairing, which could prevent the binding of
an endonuclease. Although knowledge of the individual
RNA structures would be required for validating this
model, our data showed that a SIDER2 anti-sense RNA
lacking signature II was unable to block degradation of its
target RNA. In contrast, a heterologous SIDER2 (3810)
anti-sense RNA sharing high-sequence similarity with the
sense (1270) RNA, especially within the cleavage region,
was able to prevent degradation as eﬃciently as the hom-
ologous SIDER2 anti-sense RNA. An interesting question
is whether Leishmania, in the absence of a functional
RNAi mechanism (55,56) known to silence widespread
retrotransposon elements (57), uses an anti-sense
RNA-based mechanism to mitigate regulation by
SIDER2. A large number of SIDER2 retroposons are
present in the anti-sense orientation within IRs of the
three queried Leishmania genomes (15–20% of the
SIDER2s) (21) and anti-sense RNA can in principle be
produced following polycistronic transcription and
pre-mRNA processing (3). Furthermore, several
SIDER2 retroposons have been found in the anti-sense
orientation of directional gene clusters (21), and as there
is evidence for bidirectional transcription leading to
anti-sense transcripts (2,33,58–60) in Leishmania,
SIDER2 anti-sense RNA could be produced from that
route as well. We have indeed detected anti-sense RNA
products complementary to SIDER1270 by strand-speciﬁc
RT-PCR and northern blotting using speciﬁc riboprobes,
albeit at signiﬁcantly lower levels than the sense RNA
(data not shown). However, is not to be excluded that
under certain conditions during its lifecycle, Leishmania
could produce higher levels of SIDER2 anti-sense
RNAs. In the majority of cases, anti-sense RNA action
entails post-transcriptional inhibition of target RNA
function (61), but, in a few cases, mRNA stabilizing
eﬀect by the anti-sense RNA has also been reported
(62,63). Eﬃcient targeting of an important mRNA decay
pathway in Leishmania by anti-sense RNA represents a
promising strategy towards the development of novel
therapeutics against Leishmania infections. The use of
anti-sense RNA to knockdown expression of individual
genes in Leishmania (64,65) has been limited, with a
moderate to good success.
The results reported here support a model in which
rapid turnover of unstable or short-lived SIDER2-
containing transcripts is mediated by a site-speciﬁc
endonucleolytic cleavage without prior deadenylation.
We had previously shown that rapid decay of develop-
mentally regulated transcripts in Leishmania conferred
by a U-rich 30-UTR element (URE) is deadenylation-
independent and probably not associated with elevated
decapping activities (17). Consistent with this view,
unstable transcripts in T. brucei regulated by UREs were
not aﬀected by depletion of the CAF1 deadenylase
homolog (11). Instead, a putative 50–30 exonuclease,
XRNA (12) or the exosome (16) was required for the ini-
tiation of rapid degradation of unstable mRNAs in
T. brucei. Based on this knowledge, the current model
for mRNA degradation in trypanosomatids involves at
least two pathways: a regulated pathway that is rapid
and seems to be deadenylation-independent [this study;
(4,17)] and a constitutive pathway that is initiated with a
progressive shortening of poly(A) tails (probably by the
CAF1-NOT-complex) and operates at a slower kinetics
during the degradation of stable mRNAs [this study;
(5,17)].
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